How does one optimize the safety profile of IL-6 inhibitors?

How does one optimize the safety profile of IL-6 inhibitors?

How does one optimize the safety profile of IL-6 inhibitors?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Michael Ehrenstein, MD

Michael Ehrenstein, MD

Professor of Rheumatology
University College Hospital
University College of London School of Medicine
London, UK